Skip to main content
. 2021 Feb 10;110(6):884–894. doi: 10.1007/s00392-021-01812-3

Table 1.

Baseline patient characteristics of the study population

No pre-existing
RV dilatation
N = 747
Pre-existing
RV dilatation
N = 243
P value
Age (years) 70.4 ± 12.5 70.4 ± 10.9 0.95
Female sex 285 (38.2%) 92 (37.9%) 0.94
BMI (kg/m2) 26.5 ± 4.7 26.7 ± 4.7 0.67
BSA (m2) 1.89 ± 0.23 1.89 ± 0.23 0.63
Single-chamber pacemaker 158 (23.1%) 82 (40.8%) < 0.001
RV pacing threshold (V) 0.71 ± 0.61 0.75 ± 0.63 0.80
Coronary artery disease 420 (56.2%) 147 (60.5%) 0.24
Heart failure 375 (50.2%) 145 (59.7%) 0.01
Diabetes 191 (25.6%) 68 (28.0%) 0.46
Myocarditis 3 (0.4%) 1 (0.4%) 0.98
Any atherosclerosis 498 (66.7%) 161 (66.3%) 0.91
Previous stroke or TIA 94 (12.6%) 32 (13.2%) 0.81
Previous CABG 55 (7.4%) 38 (15.6%) < 0.001
Atrial fibrillation 385 (51.5%) 169 (69.5%) < 0.001
Chronic kidney disease 183 (24.5%) 95 (39.1%) < 0.001
Endocarditis 58 (7.8%) 22 (9.1%) 0.52

Values are mean ± SD, N (%), or median (interquartile range), unless otherwise indicated. P values < 0.05 in bold

BMI body mass index, BSA body surface area, CABG coronary artery bypass grafting, RV right ventricle, TIA transient ischemic attack, V volt